Artelo biosciences selected as a finalist in johnson & johnson's innovation challenge

Art26.12 preclinical dermatology research presented to the immuno-dermatology leadership team at johnson & johnson art26.12 preclinical dermatology research presented to the immuno-dermatology leadership team at johnson & johnson
ARTL Ratings Summary
ARTL Quant Ranking